CClinicalTrials.gg
RecruitingNCT05249361Updated Nov 29, 2023

Correlation Between Functional Capacity and Functional Capability in Duchenne Muscular Dystrophy

An observational study in Duchenne Muscular Dystrophy, sponsored by Samsung Medical Center. Recruiting at 2 sites in Korea, Republic of. Open to participants aged 5 Years to 18 Years. Per ClinicalTrials.gov, last updated 2023-11-29.

Sponsored by Samsung Medical Center · Observational

From the registry’s dates

  • Primary completion was expected by Apr 2025, 1 year 6 months ago, but the record still lists the study as recruiting.
  • Started May 2023; still recruiting 3 years 5 months later.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
48
Ages
5 Years to 18 Years
Sex
All
01

Study summary

This study investigates the correlation between assessments measuring functional capacity and functional capability in patients with Duchenne muscular dystrophy.

Read the detailed description

This study is a prospective single-arm observational study, with a total of two visits for one year follow-up.

02

Conditions studied

  • Duchenne Muscular Dystrophy

Keywords

  • Duchenne Muscular Dystrophy
  • DMD
  • Accelerometer
  • ActiGraph
  • DEXA
  • muscle ultrasound
03

In context

Muscular Dystrophies

548 studies on the registry are indexed under Muscular Dystrophies; 89 are open to participants now.

This study's planned enrollment of 48 is below the median of 69 across 179 observational studies indexed under Muscular Dystrophies.

Browse Muscular Dystrophies studies →

Lead sponsor

Samsung Medical Center is the lead sponsor of 980 studies on the registry; 146 are open to participants now.

Of its 7 completed or terminated interventional studies of FDA-regulated products, 1 (14%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
5 Years to 18 Years
Sexes eligible
All
Sampling method
Probability sample

Study population

Asian patients of Duchenne muscular dystrophy, who live in South Korea and visited the Samsung medical center in Gangnam-gu, Seoul.

Inclusion criteria

  1. Children aged 5 to 18 years diagnosed with Duchenne muscular dystrophy through genetic testing
  2. Children who understand the contents of this research and can properly conduct the research

Exclusion criteria

Exclusion Criteria:

  1. Requiring daytime ventilator assistance or using invasive mechanical ventilation through tracheostomy (Non-invasive mechanical ventilation such as positive pressure ventilation at night is allowed)
  2. History of peripheral nerve damage
  3. History of major surgery within 12 weeks or if major surgery is expected during the test period
  4. History of central nervous system disorders (eg, cerebral infarction, spinal cord injury)
  5. Having difficulties in conducting this study due to cognitive decline.
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
48 participants (estimated)
Patient registry
No

Groups and cohorts

  • Duchenne Muscular Dystrophy

    Children aged 5 to 18 years with Duchenne muscular dystrophy

    Other: no intervention

Interventions

  • Otherno intervention

    no intervention

06

What researchers measure

Primary outcomes

  1. Correlation between physical activity(VM) and muscle quantitative index

    We analyze the correlation between the change in activity counts from baseline to 48-week and the change in muscle quantitative measures of upper and lower extremities from baseline to 48-week. The activity counts will be measured with ActiGraph wgt3x-bt worn on patient's dominant ankle and wrist. Accelerometers recorded acceleration in three orthogonal axes (x, y, z) at 30 Hz. Accelerometer recordings were uploaded to ActiLife software, integrated into 15-second epochs, and converted into an omnidirectional acceleration estimate, or vector magnitude (VM), calculated as the square root of the sum of the triaxial signals squared. The muscle quantitative will be measured with Microfet2. Muscle quantitative of upper extremity is the sum of the flexion and extension of both elbows and lower extremity is the sum of both knee flexion and extension and bilateral ankle dorsiflexion.

    Time frame: Baseline up to Week 48

Secondary outcomes

  1. Correlation between physical activity and Vignos scale

    We analyze the correlation between the change in activity counts from baseline to 48-week and the change in Vignos scale score from baseline to 48-week. On the Vignos scale, the grade ranges from 1 to 10; 1 means that the patient is able to walk and climb stairs without assistance, while 10 means that the patient is bed-bound

    Time frame: Baseline up to Week 48

  2. Correlation between physical activity and Brooke scale

    We analyze the correlation between the change in activity counts from baseline to 48-week and the change in Brooke scale score from baseline to 48-week. The grades on the Brooke scale range from 1 to 6; 1 means that the patient is able to start with arms at the sides and can abduct the arms in a full circle until they touch above the head, while 6 means that they are unable to raise their hands to their mouth and have no useful function of the hands.

    Time frame: Baseline up to Week 48

  3. Correlation between physical activity and 6MWT(6-minute walking test)

    We analyze the correlation between the change in activity counts from baseline to 48-week and the change in 6MWT results from baseline to 48-week. The 6MWT assesses distance walked over 6 minutes.

    Time frame: Baseline up to Week 48

  4. Correlation between physical activity and NSAA(The North Star Ambulatory Assessment)

    We analyze the correlation between the change in activity counts from baseline to 48-week and the change in NSAA scores from baseline to 48-week. The NSAA is a 17-item rating scale that is used to measure functional motor abilities in ambulant children with Duchenne Muscular Dystrophy (DMD). It includes several items assessing abilities that are necessary to remain functionally ambulant, items assessing abilities, such as head raise and standing on heels that can be partly present in the early stages of the disease and a number of activities such as hopping. Each item can be scored on a 3 point scale using simple criteria: 2 -Normal achieves goal without any assistance; 1 -Modified method but achieves goal independent of physical assistance from another person; 0 -Unable to achieve independently. A total score can be achieved by summing the scores for all the individual items. The score can range from 0, if all the activities are failed, to 34, if all the activities are achieved.

    Time frame: Baseline up to Week 48

  5. Correlation between physical activity and PUL(Performance of Upper Limb module for DMD)

    We analyze the correlation between the change in activity counts from baseline to 48-week and the change in PUL scores from baseline to 48-week. The PUL includes 22 items with an entry item to define the starting functional level (which corresponds to the Brooke scale) and 21 items subdivided into shoulder level (4 items), elbow level (9 items), and distal (i.e., wrist and fingers) level (8 items). For weaker patients, a low score on the entry item (i.e., less than 4 point of Item A) means that shoulder-level items do not need to be performed. Each dimension can be scored separately with a maximum score of 16 for the shoulder level, 34 for the elbow level, and 24 for the distal level. A total score can be achieved by adding the three-level scores, with a maximum global score of 74 points.

    Time frame: Baseline up to Week 48

  6. Correlation between physical activity and PEDI-CAT(the Pediatric Evaluation of Disability Inventory-Computer Adaptive Test)

    We analyze the correlation between the change in activity counts from baseline to 48-week and the change in mobility and self-care domain scores of PEDI-CAT from baseline to 48-week. Te PEDI-CAT incorporates a computer-adaptive platform with 276 items based on parental or caregiver reporting, and has four domains that cover daily activities, mobility, social/cognitive function, and responsibility. The PEDI-CAT yields a single score scaled from 0 to 100 for both Mobility and Self-care, with higher scores indicating greater function.

    Time frame: Baseline up to Week 48

  7. Correlation between physical activity and EQ-5D(EuroQol-5D)

    We analyze the correlation between the change in activity counts from baseline to 48-week and the change in EQ-5D from baseline to 48-week. EuroQol EQ-5D is a preference-based HRQOL measurement tool for the five dimensions of 'exercise ability', 'self-management', 'daily activity', 'pain/discomfort', and 'anxiety/depression' in terms of 'no problem', 'somewhat Evaluated on three levels of 'having a problem' and 'having a serious problem', and the overall level was evaluated on a thermometer-shaped 20 cm vertical visual analogue scale with 0 points for the lowest health and 100 points for the highest health status.

    Time frame: Baseline up to Week 48

  8. Correlation between physical activity and CHQ-PF50(Child Health Questionnaire - Parent form 50 )

    We analyze the correlation between the change in activity counts from baseline to 48-week and the change in EQ-5D from baseline to 48-week. The Child Health Questionnaire - Parent form 50 (CHQ-PF50) consists of 50 questions and 12 scales (Physical function, Role/social limitations-physical, Role/social limitations-emotional/ behavioral, Mental health, Self-esteem, Behavior, Bodily pain/discomfort, General health perceptions, Family activities, Parent impact on time, Parent emotional impact) and 2 global items (Global behavior and global general health), 2 summary scores (Physical and a psychosocial summary scores) is a tool to evaluate the quality of life of children. The raw score is converted into a converted score between 0-100, and the higher the score, the better the quality of life.

    Time frame: Baseline up to Week 48

  9. Correlation between physical activity and quantitative muscle ultrasonography

    We analyze the correlation between change in activity from baseline to 48-week and the change in quantitative muscle ultrasonography from baseline to 48-week. We will measure the echogenicity of the muscles at 12 sites including deltoid, biceps brachii, wrist/finger flexors, rectus femoris, tibialis anterior, medial gastrocnemius, masseter, sternocleidomastoid, geniohyoid and diaphragm. The average gray scale of above muscles will be analyzed with ImageJ software (https://imagej.nih.gov).

    Time frame: Baseline up to Week 48

  10. Correlation between physical activity and DMD upper limb PROM

    We analyze the correlation between change in activity from baseline to 48-week and the change in DMD upper limb PROM from baseline to 48-week. DMD upper limb PROM is a patient reported outcome measure designed to assess upper extremity performance in daily life. It includes 32 items and each item will be scored on a 3 point scale: 2-can do task easily; 1-can do tast with difficulty; 0-impossible without help. A total score is the summation of the scores for all individual items. The score can range from 0 to 64.

    Time frame: Baseline up to Week 48

  11. Correlation between physical activity and Pulmonary function test

    We analyze the correlation between change in activity from baseline to 48-week and the change in pulmonary function test from baseline to 48-week. Maximal inspiratory pressure and maximal expiratory pressure will be measured with spirometry (Spirovis, Cosmed Srl, Rome, Italy).

    Time frame: Baseline up to Week 48

07

Study locations

2 of 2 sites recruiting
  • Samsung Medical Center
    Seoul, 06135, Korea, Republic of
    Recruiting
  • Samsung Medical Center
    Seoul, 06351, Korea, Republic of
    • JEONG-YI KWON, MD, PHD · Contact · jeongyi.kwon@samsung.com · +8210-4591-1039
    • JEONG-YI KWON, MD · Principal investigator
    Recruiting
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 29, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05249361
Lead sponsor
Samsung Medical Center
Responsible party
Jeong Yi Kwon (Professor, Samsung Medical Center) — Principal investigator
First posted
Feb 21, 2022
Start date
May 1, 2023
Primary completion
Apr 1, 2025 (estimated)
Completion
Oct 1, 2025 (estimated)
Last update
Nov 29, 2023

Study contacts

Yumi Choe
Contact
yumi.choe@sbri.co.kr
82-010-3173-2671
Jeong-yi Kwon, MD,Ph.D
principal investigator · Samsung Medical Center

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion